Dashboard
Manage Tickers

EVAXEvaxion Biotech A/S

Nasdaq evaxion-biotech.com


$ 3.45 $ 0.24 (7.34 %)    

Monday, 19-Aug-2024 14:36:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.33 $ 3.67 (0.77 %)
DIA $ 408.71 $ 1.28 (0.31 %)
SPY $ 558.30 $ 3.41 (0.61 %)
TLT $ 97.92 $ -0.02 (-0.02 %)
GLD $ 231.47 $ 1.27 (0.55 %)
$ 3.214
$ 3.44
$ 3.06 x 100
-- x --
$ 3.44 - $ 3.46
$ 2.26 - $ 13.61
20,883
na
121.8M
$ 1.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
08/16/2024 09:42:38

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

evaxion-biotechs-cash-position-of-8m-as-of-june-30-2024-is-expected-to-be-sufficient-to-fund-its-operating-expenses-and-capital-expenditure-requirements-into-february-2025
Evaxion Biotech's Cash Position Of $8M As ...
08/14/2024 11:05:04

evaxion-biotech-q2-2024-gaap-eps-012-beats-026-estimate-sales-154000k-beat-52000k-estimate
Evaxion Biotech Q2 2024 GAAP EPS $(0.12) B...
08/14/2024 11:04:08

evaxion-to-present-1-year-clinical-efficacy-data-from-its-phase-2-study-on-lead-cancer-vaccine-candidate-evx-01-at-the-esmo-congress-2024
Evaxion To Present 1-Year Clinical Efficac...
08/08/2024 12:05:57

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunolog...

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
08/01/2024 12:20:05

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

evaxion-ceo-christian-kanstrup-reinforces-milestone-timeline-and-provides-shareholder-update
Evaxion CEO Christian Kanstrup Reinforces ...
07/03/2024 12:13:30

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

evaxion-on-patent-application-for-ai-based-novel-cancer-vaccine-target-identification-method-says-an-international-preliminary-report-on-patentability-indicates-promising-prospects-for-obtaining-granted-patents-and-protecting-the-invention
Evaxion, On Patent Application for AI-Base...
06/26/2024 11:31:59

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
06/19/2024 20:30:52

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

evaxion-announces-publication-of-data-from-phase-1-dose-escalation-study-of-evx-01-in-journal-for-immunotherapy-of-cancer--demonstrating-67-objective-response-rate
Evaxion Announces Publication Of Data From...
06/17/2024 12:46:33

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
06/04/2024 11:17:30

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

evaxion-presents-validating-immune-data-from-ongoing-phase-2-trial-with-ai-designed-evx-01-vaccine-at-the-asco-annual-meeting-2024
Evaxion Presents Validating Immune Data Fr...
06/03/2024 12:47:34

Evaxion's AI-designed cancer vaccine, EVX-01, triggered a specific and tumor-targeting immune response in all assayed melan...

evaxion-biotech-q1-eps-003-beats-056-estimate-sales-5100k-beat-3700k-estimate
Evaxion Biotech Q1 EPS $0.03 Beats $(0.56)...
05/28/2024 12:30:00

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.5...

evaxion-received-a-letter-from-the-nasdaq-listing-qualifications-department-notifying-that-it-is-not-currently-in-compliance-with-the-minimum-stockholders-equity-requirement
Evaxion Received A Letter From The Nasdaq ...
05/10/2024 21:03:50

Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing i...

evaxion-biotech-files-for-for-offer-and-sale-of-up-to-1945m-ordinary-shares-represented-by-1945m-adss-by-selling-shareholders
Evaxion Biotech Files For For Offer And Sa...
05/06/2024 21:12:04

evaxion-announces-first-patient-completed-dosing-with-personalized-cancer-vaccine-evx-01
Evaxion Announces First Patient Completed ...
04/17/2024 12:09:57

hc-wainwright--co-reiterates-buy-on-evaxion-biotech-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Evax...
04/03/2024 10:41:18

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 16:31:06

ladenburg-thalmann-upgrades-evaxion-biotech-to-buy-announces-8-price-target
Ladenburg Thalmann Upgrades Evaxion Biotec...
04/02/2024 15:39:13

Ladenburg Thalmann analyst Ahu Demir upgrades Evaxion Biotech (NASDAQ:EVAX) from Neutral to Buy and announces $8 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION